Strategies for Peptide-Mediated Cargo Delivery to Human Smooth Muscle Cells

Area of Science:

• Biomedical Engineering
• Pharmacology
• Cell Biology

Background:

• Smooth muscle cell dysfunction underlies significant diseases, including cardiovascular conditions and preterm birth.
• Current therapies for these conditions are often insufficient, necessitating novel drug delivery strategies.
• Cell penetrating peptides (CPPs) are a potential but underexplored tool for targeted drug delivery.

Purpose of the Study:

• To investigate the efficacy and safety of using cell penetrating peptides (CPPs) for drug delivery to human smooth muscle cells and tissues.
• To address the knowledge gap regarding CPP application in human uterine and vascular smooth muscle cells.

Main Methods:

• Examined the uptake of four different CPP-fluorophore conjugates (1309-3435 Da, +2 to +7 charge) in isolated human uterine smooth muscle cells.
• Assessed the delivery of fluorescent moieties and biologically active peptides via CPPs.
• Evaluated CPP delivery to native smooth muscle cells in human tissues ex vivo within a short timeframe.

Main Results:

• CPP-fluorophore conjugates were successfully delivered to human uterine smooth muscle cells without observed toxicity.
• CPPs demonstrated the capacity to deliver both fluorescent markers and biologically active peptides.
• Effective CPP delivery to native smooth muscle cells in human tissues ex vivo was achieved rapidly.

Conclusions:

• Cell penetrating peptides (CPPs) represent a viable and non-toxic method for delivering cargo to human smooth muscle cells.
• CPPs facilitate the delivery of therapeutic payloads to native human smooth muscle tissues.
• Further research into CPPs can advance understanding of smooth muscle dysfunction diseases and therapeutic interventions.